Literature DB >> 17428614

Prostaglandin transporter expression in mouse brain during development and in response to hypoxia.

S Scafidi1, R M Douglas, R Farahani, K J Banasiak, G G Haddad.   

Abstract

Prostaglandins (PGs) are bioactive lipid mediators released following brain hypoxic-ischemic injury. Clearance and re-uptake of these prostaglandins occur via a transmembrane prostaglandin transporter (PGT), which exchanges PG for lactate. We used Western blot analyses to examine the PGT developmental profile and its regional distribution as well as changes in transporter expression during chronic hypoxia in the neonatal mouse brain. Microsomal preparations from four brain regions (cortex, hippocampus, cerebellum and brainstem/diencephalon) showed gradual increases in prostaglandin transporter expression in all brain regions examined from postnatal day 1 till day 30. There was a significant regional heterogeneity in the prostaglandin transporter expression with highest expression in the cortex, followed by cerebellum and hippocampus, and least expressed in the brainstem/diencephalon. To further delineate the pattern of prostaglandin transporter expression, separate astrocytic and neuronal microsomal preparations were also examined. In contrast to neurons, which had a robust expression of prostaglandin transporters, astrocytes had very little PGT expression under basal conditions. In response to chronic hypoxia, there was a significant decline in PGT expression in vivo and in neurons in vitro, whereas cultured astrocytes increased their PGT expression. This is the first report on PGT expression in the CNS and our studies suggest that PGTs have 1) a widespread distribution in the CNS; 2) a gradual increase and a differential expression in various regions during brain development; and 3) striking contrast in expression between glia and neurons, especially in response to hypoxia. Since PGTs play a role as prostaglandin-lactate exchangers, we hypothesize that PGTs are important in the CNS during stress such as hypoxia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17428614      PMCID: PMC2661356          DOI: 10.1016/j.neuroscience.2007.02.042

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  53 in total

1.  Cyclooxygenase-2 contributes to functional hyperemia in whisker-barrel cortex.

Authors:  K Niwa; E Araki; S G Morham; M E Ross; C Iadecola
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

2.  Perinatal changes in choroidal 15-hydroxyprostaglandin dehydrogenase: implications for prostaglandin removal from brain.

Authors:  N Krunic; S L Adamson; C Ackerley; R T Okita; F Coceani
Journal:  Brain Res Dev Brain Res       Date:  2000-06-30

3.  Alpha-cyano-4-hydroxycinnamate decreases both glucose and lactate metabolism in neurons and astrocytes: implications for lactate as an energy substrate for neurons.

Authors:  M C McKenna; I B Hopkins; A Carey
Journal:  J Neurosci Res       Date:  2001-12-01       Impact factor: 4.164

4.  Cyclooxygenase-2 does not contribute to postischemic production of reactive oxygen species.

Authors:  Alexander Kunz; Josef Anrather; Ping Zhou; Marcello Orio; Costantino Iadecola
Journal:  J Cereb Blood Flow Metab       Date:  2006-07-05       Impact factor: 6.200

5.  Tubulin and actin synthesis during brain development.

Authors:  R N Bryan; J Bossinger; M Hayashi
Journal:  Dev Biol       Date:  1981-01-30       Impact factor: 3.582

6.  Receptor-mediated phosphorylation of astroglial intermediate filament proteins in cultured astroglia.

Authors:  K D McCarthy; J Prime; T Harmon; R Pollenz
Journal:  J Neurochem       Date:  1985-03       Impact factor: 5.372

Review 7.  Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases.

Authors:  Luisa Minghetti
Journal:  J Neuropathol Exp Neurol       Date:  2004-09       Impact factor: 3.685

8.  Prostanoids, not reactive oxygen species, mediate COX-2-dependent neurotoxicity.

Authors:  Yasuhiro Manabe; Josef Anrather; Takayuki Kawano; Kiyoshi Niwa; Ping Zhou; M Elizabeth Ross; Costantino Iadecola
Journal:  Ann Neurol       Date:  2004-05       Impact factor: 10.422

9.  Effects of triflusal on oxidative stress, prostaglandin production and nitric oxide pathway in a model of anoxia-reoxygenation in rat brain slices.

Authors:  J A González-Correa; M M Arrebola; I M Ureña; A Guerrero; J Muñoz-Marín; D Ruiz-Villafranca; F Sánchez De La Cuesta; J P De La Cruz
Journal:  Brain Res       Date:  2004-06-18       Impact factor: 3.252

10.  Postnatal hypoxic-ischemic brain injury alters mechanisms mediating neuronal glucose transport.

Authors:  Ann Zovein; Judy Flowers-Ziegler; Shanthie Thamotharan; Don Shin; Raman Sankar; Khoi Nguyen; Sanjiv Gambhir; Sherin U Devaskar
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2003-10-02       Impact factor: 3.619

View more
  7 in total

Review 1.  The physiology of developmental changes in BOLD functional imaging signals.

Authors:  Julia J Harris; Clare Reynell; David Attwell
Journal:  Dev Cogn Neurosci       Date:  2011-04-27       Impact factor: 6.464

2.  Chronic hypoxia-induced alterations of key enzymes of glucose oxidative metabolism in developing mouse liver are mTOR dependent.

Authors:  Vikas V Dukhande; Girish C Sharma; James C K Lai; Reza Farahani
Journal:  Mol Cell Biochem       Date:  2011-05-28       Impact factor: 3.396

3.  Expression and localization of prostaglandin transporter in Alzheimer disease brains and age-matched controls.

Authors:  Koyi Choi; Hean Zhuang; Barbara Crain; Sylvain Doré
Journal:  J Neuroimmunol       Date:  2008-03-18       Impact factor: 3.478

Review 4.  Targeted drug delivery to treat pain and cerebral hypoxia.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Pharmacol Rev       Date:  2013-01-23       Impact factor: 25.468

Review 5.  The Prostaglandin Transporter: Eicosanoid Reuptake, Control of Signaling, and Development of High-Affinity Inhibitors as Drug Candidates.

Authors:  Victor L Schuster; Yuling Chi; Run Lu
Journal:  Trans Am Clin Climatol Assoc       Date:  2015

Review 6.  Transport Mechanisms at the Blood-Brain Barrier and in Cellular Compartments of the Neurovascular Unit: Focus on CNS Delivery of Small Molecule Drugs.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Pharmaceutics       Date:  2022-07-20       Impact factor: 6.525

7.  Molecular cloning and characterization of the porcine prostaglandin transporter (SLCO2A1): evaluation of its role in F4 mediated neonatal diarrhoea.

Authors:  Mario Van Poucke; Vesna Melkebeek; Tim Erkens; Alex Van Zeveren; Eric Cox; Luc J Peelman
Journal:  BMC Genet       Date:  2009-10-06       Impact factor: 2.797

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.